New study shows dramatic difference in incidence of tumor formation based on presence of NEDD9Researchers at Fox Chase Cancer Center have identified a potentially significant molecular player in the d... [Read More]
A long-term international study shows that the drug raloxifene is almost as effective in preventing breast cancer among high-risk women as the related drug tamoxifen, but with far fewer dangerous side... [Read More]
The breast cancer drug tamoxifen prevented more cases of breast cancer after nearly 7 years than Eli Lilly and Co's osteoporosis drug Evista, researchers reported on Monday.... [Read More]
Older women at higher risk for breast cancer now have two good drug options for preventing the disease, but they will have to weigh the trade-offs, a major study shows.... [Read More]
MONDAY, April 19 (HealthDay News) -- The latest results from a landmark, long-running study find that both tamoxifen and raloxifene help prevent breast cancer in postmenopausal women, although some di... [Read More]
One of Australia's leading breast cancer researchers has dismissed a Swedish study which found women taking multivitamins had a higher risk of developing breast cancer.... [Read More]
UnitedProject.org Inc. (c) 2006-2008 All content published on UnitedProject.org is provided for informational purposes only and is not meant to substitute for the advice, diagnosis or treatment provided by your physician or other healthcare professionals.
If you think you are experiencing a medical problem or an emergency please contact your physician, local emergency room or call 911. Healthcare benefits and discounts are not insurance and not intended as a substitute for health insurance. Except when other source is cited, all content posted by members is licensed under Creative Commons Public Domain License.
